‘Pharma Bro’ Shkreli Fails to Toss FTC, State Antitrust Case

Convicted ‘Pharma-Bro’ Martin Shkreli must face a Federal Trade Commission antitrust suit over his move to raise the price of parasite treatment drug Daraprim by nearly 4,000%, a federal judge ruled.

Judge Denise Cote of the U.S. District Court for the Southern District of New York denied requests by Shkreli and other defendants named in the suit to dismiss the case brought by the FTC and a group of state attorneys general on all but one claim.

The FTC and the state of New York sued Shkreli in January for allegedly violating antitrust law when he acquired and then immediately ...